BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 30521462)

  • 1. [The Role of Testosterone in The Improvement of Sexual Desire in Postmenopausal Women: An Evidence-Based Clinical Review].
    Gouveia M; Sanches R; Andrade S; Carmona S; Ferreira C
    Acta Med Port; 2018 Nov; 31(11):680-690. PubMed ID: 30521462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Krapf JM; Simon JA
    Maturitas; 2009 Jul; 63(3):213-9. PubMed ID: 19487090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Kingsberg SA; Simon JA; Goldstein I
    J Sex Med; 2008 Sep; 5 Suppl 4():182-93; quiz 193. PubMed ID: 18783534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?
    Schover LR
    Fertil Steril; 2008 Jul; 90(1):129-40. PubMed ID: 18023435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which Postmenopausal Women Should Use Testosterone for Low Sexual Desire?
    Slomski A
    JAMA; 2020 Feb; 323(6):493-495. PubMed ID: 31968073
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial comments on "the current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women".
    Goldstein I
    J Sex Med; 2008 Sep; 5 Suppl 4():177-8. PubMed ID: 18783531
    [No Abstract]   [Full Text] [Related]  

  • 7. Androgen Therapy in Women.
    Vegunta S; Kling JM; Kapoor E
    J Womens Health (Larchmt); 2020 Jan; 29(1):57-64. PubMed ID: 31687883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis.
    Achilli C; Pundir J; Ramanathan P; Sabatini L; Hamoda H; Panay N
    Fertil Steril; 2017 Feb; 107(2):475-482.e15. PubMed ID: 27916205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Davis SR; Braunstein GD
    J Sex Med; 2012 Apr; 9(4):1134-48. PubMed ID: 22304681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone for women: necessary or noxious?
    Katz A
    AWHONN Lifelines; 2006; 10(3):208-9. PubMed ID: 16792707
    [No Abstract]   [Full Text] [Related]  

  • 11. Testosterone therapy and other treatment modalities for female sexual dysfunction.
    Ingram CF; Payne KS; Messore M; Scovell JM
    Curr Opin Urol; 2020 May; 30(3):309-316. PubMed ID: 32205812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone therapy in women: a review.
    Bolour S; Braunstein G
    Int J Impot Res; 2005; 17(5):399-408. PubMed ID: 15889125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen therapy in women, beyond libido.
    Davis SR
    Climacteric; 2013 Aug; 16 Suppl 1():18-24. PubMed ID: 23647457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone therapy for sexual dysfunction in postmenopausal women.
    Hubayter Z; Simon JA
    Climacteric; 2008 Jun; 11(3):181-91. PubMed ID: 18568783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding and succeeding the advent of phosphodiesterase type 5 inhibitors.
    Reis SL; Abdo CH
    Clinics (Sao Paulo); 2014; 69(4):294-303. PubMed ID: 24714838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of female sexual dysfunction in postmenopausal women by testosterone administration: safety issues and controversies.
    Braunstein GD
    J Sex Med; 2007 Jul; 4(4 Pt 1):859-66. PubMed ID: 17627735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder.
    White WB; Grady D; Giudice LC; Berry SM; Zborowski J; Snabes MC
    Am Heart J; 2012 Jan; 163(1):27-32. PubMed ID: 22172433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen treatment of postmenopausal women.
    Davis SR; Worsley R
    J Steroid Biochem Mol Biol; 2014 Jul; 142():107-14. PubMed ID: 23727129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone for low libido in postmenopausal women not taking estrogen.
    Davis SR; Moreau M; Kroll R; Bouchard C; Panay N; Gass M; Braunstein GD; Hirschberg AL; Rodenberg C; Pack S; Koch H; Moufarege A; Studd J;
    N Engl J Med; 2008 Nov; 359(19):2005-17. PubMed ID: 18987368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
    Simon J; Braunstein G; Nachtigall L; Utian W; Katz M; Miller S; Waldbaum A; Bouchard C; Derzko C; Buch A; Rodenberg C; Lucas J; Davis S
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5226-33. PubMed ID: 16014407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.